Citation: | SUN Haiyong, GUAN Bing, MA Wei. Analysis in compliance and withdraw reasons of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 41-45. DOI: 10.7619/jcmp.20234073 |
To explore the compliance and withdraw factors of sublingual immunotherapy (SLIT) with dermatophagoides farinae drops in patients with allergic rhinitis (AR).
A retrospective analysis was conducted in 652 AR patients with dermatophagoides farinae drops for SLIT, and the withdraw time and reasons were recorded.
Of the 652 patients, 516 cases were successfully followed up, and 291 dropped out halfway, with an overall compliance rate of 43.60%. Among the patients with successful follow up, those aged < 14 years old had better compliance than those aged ≥14 years old, and there was no significant difference in the withdraw rate according to factor of gender. The months with the highest withdraw rate were the fifth, the sixth and the seventh months after administration of drugs.
The overall compliance of AR patients with SLIT is poor, and children aged < 14 years old have better compliance than those aged ≥14 years old. Strengthening patient's education, increasing the frequency of follow-up, and building an effective communication platform can help improve patient's compliance.
[1] |
中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年, 修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 106-129. doi: 10.3760/cma.j.cn115330-20211228-00828
|
[2] |
JIN M, ZHANG L, ZHOU G J, et al. The effect of the standard length of the first prescription on the adherence to sublingual immunotherapy for patients with allergic rhinitis[J]. Int Forum Allergy Rhinol, 2020, 10(6): 768-772. doi: 10.1002/alr.22553
|
[3] |
LOU H F, HUANG Y R, OUYANG Y H, et al. Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial[J]. Allergy, 2020, 75(8): 2026-2036. doi: 10.1111/all.14218
|
[4] |
VOGELBERG C, BRVGGENJVRGEN B, RICHTER H, et al. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma[J]. Patient Prefer Adherence, 2020, 14: 817-827. doi: 10.2147/PPA.S242957
|
[5] |
朱鲁平, 隗萍, 林旸, 等. 影响变应性鼻炎舌下免疫治疗依从性的因素分析[J]. 中国中西医结合耳鼻咽喉科杂志, 2021, 7(3): 205-208. https://www.cnki.com.cn/Article/CJFDTOTAL-XYJH202103011.htm
|
[6] |
OWENIER C, BARNOWSKI C, LEINEWEBER M, et al. Tolerability and safety of sublingual immunotherapy in patients with tree pollen allergy in daily practice-an open, prospective, non-interventional study[J]. J Clin Med, 2023, 12(17): 5517. doi: 10.3390/jcm12175517
|
[7] |
安羽三, 欧阳昱晖. 季节性过敏性鼻炎的研究现状[J]. 中国耳鼻咽喉头颈外科, 2020, 27(4): 199-201. https://www.cnki.com.cn/Article/CJFDTOTAL-EBYT202004008.htm
|
[8] |
PARK M, KAPOOR S, YI J L, et al. Sublingual immunotherapy persistence and adherence in real-world settings: a systematic review[J]. Int Forum Allergy Rhinol, 2023, 13(5): 924-941. doi: 10.1002/alr.23086
|
[9] |
KLEIN T M, HADLER M, AUGUSTIN M, et al. Patient needs and benefits of sublingual immunotherapy for grass pollen-induced allergic rhinitis: an observational study[J]. Immunotherapy, 2021, 13(14): 1193-1204. doi: 10.2217/imt-2021-0161
|
[10] |
TANKERSLEY M, HAN J K, NOLTE H. Clinical aspects of sublingual immunotherapy tablets and drops[J]. Ann Allergy Asthma Immunol, 2020, 124(6): 573-582. doi: 10.1016/j.anai.2019.12.025
|
[11] |
潘晗, 张勇, 朱亚骄, 等. 舌下免疫治疗变应性鼻炎患者的脱落特点分析[J]. 中国耳鼻咽喉颅底外科杂志, 2021, 27(4): 387-390. https://www.cnki.com.cn/Article/CJFDTOTAL-ZEBY202104005.htm
|
[12] |
曹成, 许昱. 变应性鼻炎患者舌下免疫治疗的临床依从性192例分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 114-118. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYU201901024.htm
|
[13] |
KIEL M A, RÖDER E, GERTH VAN WIJK R, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy[J]. J Allergy Clin Immunol, 2013, 132(2): 353-360, e2. doi: 10.1016/j.jaci.2013.03.013
|
[14] |
BARBERI S, CIPRANDI G, VERDUCI E, et al. Effect of high-dose sublingual immunotherapy on respiratory infections in children allergic to house dust mite[J]. Asia Pac Allergy, 2015, 5(3): 163-169. doi: 10.5415/apallergy.2015.5.3.163
|
[15] |
袁章流, 何永超, 陈孝仲, 等. 二倍维持量粉尘螨滴剂脱敏疗法对变应性鼻炎的疗效及脱落率评估[J]. 中国中西医结合耳鼻咽喉科杂志, 2015, 23(5): 323-327. https://www.cnki.com.cn/Article/CJFDTOTAL-XYJH201505004.htm
|
[16] |
KULALERT P, PHINYO P, LAO-ARAYA M. Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: a systematic review and meta-analysis[J]. World Allergy Organ J, 2022, 15(9): 100691. doi: 10.1016/j.waojou.2022.100691
|
[17] |
FIELD K, BLAISS M S. Sublingual versus subcutaneous immunotherapy for allergic rhinitis: what are the important therapeutic and real-world considerations[J]. Curr Allergy Asthma Rep, 2020, 20(9): 45. doi: 10.1007/s11882-020-00934-4
|
[18] |
曹樱子, 冯彦, 王倩, 等. 蒿属花粉变应性鼻炎舌下免疫治疗的依从性现状调查[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(6): 448-452. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202306008.htm
|
[19] |
夏彩风, 颜榕, 王全桂. 245例变应性鼻炎患者舌下免疫治疗的依从性及脱落原因分析[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(4): 277-281. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202304008.htm
|
[20] |
EGERT-SCHMIDT A M, KOLBE J M, MUSSLER S, et al. Patients' compliance with different administration routes for allergen immunotherapy in Germany[J]. Patient Prefer Adherence, 2014, 8: 1475-1481.
|